Clinical Trial Update: Food Matrix and Genetic Variability as Determinants of Bioavailability and Biological Effects of Beta-cryptoxanthin and Phytosterols [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating how food matrix and genetic variability influence the bioavailability and biological effects of beta-cryptoxanthin and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia
• Osteoporosis

Drugs mentioned

• Phytosterols (phytosterols)
• beta-cryptoxanthin (beta-cryptoxanthin)

Snippet

Sponsor: Puerta de Hierro University Hospital | Conditions: Hypercholesterolemia, Osteoporosis | Phase 1 | Status: COMPLETED